Sunnyvale, Calif., January
24, 2008
ProCure Treatment Centers, Inc (ProCure) has announced that it has
selected IMPAC Medical Systems, an Elekta Company, as a
preferred provider of oncology information systems (OIS) for its
IBA-equipped proton beam therapy centers. ProCure designs,
builds and operates proton beam therapy centers in partnership
with local radiation oncologists and community hospitals.
A key component of developing proton beam therapy centers is the
staffing and training of all the center’s employees. ProCure
will have IMPAC’s MOSAIQ™ OIS software installed at its training
and development center (TDC) in Bloomington, IN. IMPAC will
provide training at the TDC for the staff of ProCure’s IBA-equipped
proton therapy centers.
“ProCure’s training and development center will ensure that
their staff is highly trained, efficient and ready to provide
the highest level of care when a proton center opens,” said
Stewart Pegrum, Global Business Manager Particle Therapy, at
Elekta. “The TDC is the first facility dedicated to training the
highly-skilled professionals needed for proton therapy. The
availability of the MOSAIQ OIS system at the TDC will enable
ProCure to both train personnel, and to optimize the therapy
workflow of the ProCure treatment centers.”
Construction is underway on the Oklahoma ProCure Treatment
Center in Oklahoma City, Oklahoma and the facility is expected
to begin treating patients in the summer of 2009. The facility
will utilize MOSAIQ OIS software.
ProCure currently has a second facility in development in
Chicago’s western suburbs; a certificate of need application is
before the Illinois Healthcare Facilities Planning Board. If
regulatory approvals are received by the spring of 2008, it is
expected patients will be able to receive treatment by mid-2010.
MOSAIQ currently is deployed at the Francis Burr Proton Therapy
Center at Massachusetts General Hospital, MD Anderson,
University of Florida Proton Therapy Institute and the Midwest
Proton Radiotherapy Institute. “The IMPAC team brings
significant expertise in proton therapy and radiation oncology
with their software solution and more importantly the associated
service,” said Niek Schreuder, Senior Vice President of
Technology at ProCure Treatment Centers. “Elekta and IMPAC share
the ProCure vision of making the OIS the central hub for all the
therapy workflow, and together we can make this happen. This
will provide significant benefits to our physician partners,
hospital partners and their patients,” added Schreuder.
About Elekta
Elekta is an international medical technology group, providing
oncologists, radiation therapists, neurosurgeons and many other
medical specialists with state of the art tools to fight serious
disease.
Elekta provides advanced clinical solutions, comprehensive
management and information systems as well as services for
improved cancer care and management of brain disorders.
Elekta’s systems and solutions are used in over 4,500 hospitals
around the world. Clinical and information management solutions
include, among others, Leksell Gamma Knife® for non-invasive
treatment of brain disorders, Elekta Axesse™ and Elekta Synergy®
for stereotactic and image guided radiation therapy and
radiosurgery as well as the MOSAIQ™ suite of software for
image-enabled EMR and efficient management of clinical and
patient data.
With over 2,000 employees globally, the corporate headquarter is
located in Stockholm, Sweden and the company is listed on the
Nordic Exchange under the ticker EKTAb. More information about
Elekta can be found at
www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries: Peter Gaccione
Vice President,
Global Marketing
Tel: +1 770-670-2380
peter.gaccione@elekta.com
Investor inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
|
